HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heba M Ismail Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

10/2021Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts.
11/2020One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.
11/2020The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.
1/2020Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals.
1/2019Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes.
1/2018The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
1/2018The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.
3/2015First test effect in intravenous glucose tolerance testing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heba M Ismail Research Topics

Disease

8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021 - 03/2015
3Insulin Resistance
01/2022 - 01/2019
2Osteoarthritis
01/2016 - 07/2015
1Cystic Fibrosis (Mucoviscidosis)
10/2021
1Arthralgia (Joint Pain)
07/2021
1Graves Disease (Basedow Disease)
07/2021
1Hypersensitivity (Allergy)
07/2021
1Urticaria (Hives)
07/2021
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Brain Edema (Cerebral Edema)
01/2018
1Hypoglycemia (Reactive Hypoglycemia)
01/2018
1Rheumatoid Arthritis
07/2015
1Liver Neoplasms (Liver Cancer)
01/2015
1Hepatocellular Carcinoma (Hepatoma)
01/2015
1Carcinoma (Carcinomatosis)
01/2015
118-Hydroxylase deficiency
07/2014
1Herpetic Stomatitis
07/2014
1Dehydration (Water Stress)
07/2014
1Familial Hypoadrenocorticism
07/2014

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
10/2021 - 01/2018
7C-PeptideIBA
10/2021 - 03/2015
5AutoantibodiesIBA
10/2021 - 01/2018
3Insulin (Novolin)FDA Link
01/2022 - 03/2015
2Aggrecans (Aggrecan)IBA
01/2016 - 07/2015
1Dipeptidyl-Peptidase IV InhibitorsIBA
10/2021
1thyrotropin-binding inhibitory immunoglobulinIBA
07/2021
1Prednisone (Sone)FDA LinkGeneric
07/2021
1Pharmaceutical PreparationsIBA
07/2021
1Cetirizine (Zyrtec)FDA LinkGeneric
07/2021
1Iodide Peroxidase (Deiodinase)IBA
07/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2021
1Methimazole (Thiamazole)FDA LinkGeneric
07/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Interleukin-1 (Interleukin 1)IBA
07/2015
1CytokinesIBA
07/2015
1MicroRNAs (MicroRNA)IBA
01/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2014
1MineralocorticoidsIBA
07/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2014
118-Hydroxycorticosterone (18 Hydroxycorticosterone)IBA
07/2014

Therapy/Procedure

2Therapeutics
01/2019 - 01/2019
1Length of Stay
01/2018
1Drug Therapy (Chemotherapy)
01/2015